Articles
Articles and analyses from the INET community on the key economic questions of our time.
Article
The Long Goodbye? Mitch McConnell and Big Money Politics
In a political system whose primary currency is not the vote but the dollar, McConnell’s role as leader has plainly been well-earned.
Article
Experts: Negotiating Big Pharma's Prices Won't Stifle Innovation—They Don't Use the Money to Innovate!
Industry lobbyists vehemently oppose Medicare drug price negotiations. However, physician-scientist Fred Ledley and economist William Lazonick debunk their arguments.
Article
How Should the Government Negotiate Medicare Drug Prices? A Guide for the Perplexed
The “maximum fair price” for a drug must not only be equitable to those with unmet medical needs who may benefit from the use of the drug but also provide equitable returns on both public and private sector investments.